Link between serum uric acid and pancreatic beta-cell function in drug naïve subjects with type 2 diabetes treated with sitagliptin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Link between serum uric acid and pancreatic beta-cell function in drug naïve subjects with type 2 diabetes treated with sitagliptin

Published:2020-11-30 Issue:2 Volume:49 Page:71-78
ISSN:2154-8331
Container-title:Hospital Practice
language:en
Short-container-title:Hospital Practice

Author:

Kutoh Eiji¹²³,Wada Askuka²,Kuto Alexandra N.¹,Hayashi Jyunka²,Kurihara Rumi²

Affiliation:

1. Division of Clinical Research, Biomedical Center, Tokyo, Japan

2. Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan

3. Division of Diabetes and Metabolism, Department of Internal Medicine, Higashitotsuka Memorial Hospital, Yokohama, Japan

Funder

manuscript

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21548331.2020.1847905

Reference27 articles.

1. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes

3. Pharmacological management of type 2 diabetes: what’s new in 2017?

4. A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials

5. Alogliptin as an initial therapy in patients with newly diagnosed, drug naïve type 2 diabetes: a randomized, control trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2022-04-17

2. Harmful versus beneficial effects of using short-term combined oral antidiabetic therapy: ‎An open label comparative clinical trial ‎;Clinical Diabetology;2021-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3